Showing papers in "IJC Heart & Vasculature in 2020"

TL;DR: The available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) is reviewed and disease management approaches and potential treatment options for COVID-19 infected AF patients are discussed.

TL;DR: Cardiac involvement as a possible late phenomenon of the viral respiratory infection is an issue that should be anticipated in patients with COVID-19 and combination of proper triage, close monitoring, and avoidance of some drugs that have cardiovascular toxicity are important in the management of cardiovascular system involvement.

TL;DR: The cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19 are reviewed.

TL;DR: The high prevalence of SA detected in this study may indicate that SA is under-recognized in patients with AF, and none of the screening questionnaires predicted SA reliably.

TL;DR: Evidence from computational modelling, pre-clinical and clinical studies illustrates that molecular abnormalities found in BrS lead to alterations in excitation wavelength (λ), which ultimately elevates arrhythmic risk.

TL;DR: In a real world scenario, sacubitril/valsartan was associated with an improved RV function and improvement in PAsP and TAPSE were independent of left ventricular improvements except for P asP and end-systolic volumes.

TL;DR: ACEi/ARB exposure does not seem to increase the risk of having the SARS-CoV-2 infection or developing severe stages of the disease including mortality and the potential benefits observed in mortality of hypertensive patients reassure safety, but robust studies are required to increaseThe confidence in the results.

TL;DR: It is believed that it is time for a new paradigm shift from the STEMI/non-STEMI to the ACOMI/ non-ACOMI in the acute management of MI.

TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to natural disasters.

TL;DR: This paper describes how a remote on-demand mobile health infrastructure was implemented based on a mobile phone app using photoplethysmography (PPG) technology allowing rate and rhythm monitoring through teleconsultations to be implemented in atrial fibrillation clinics.

TL;DR: Potential countermeasures such as α-tocopherol and captopril target these oxidative pathways and may help to protect against the effects of microgravity and radiation-induced cardiac damage, but more research needs to be conducted in this area to facilitate a safe passage for humans to the Moon, Mars and beyond.

TL;DR: It is suggested that cardiovascular comorbidities are common in patients with CO VID-19 and such patients are at higher risk of morbidity and mortality, and the continuation of clinically indicated ACE inhibitor and ARB medications is recommended in COVID-19.

TL;DR: Analysis of data for STEMI presentations at a 24-hour primary percutaneous coronary intervention center in the Republic of Ireland found any variation in the pattern of presentation was felt to likely be secondary to the current COVID-19 pandemic and resultant lockdown measures.

TL;DR: The aim of this study was to determine the influence of ACEi and ARBs on COVID-19 mortality and length of hospital stay and to reassure patients and clinicians that prescription of an ACEi or ARB at the time of CO VID-19 diagnosis is not harmful.

TL;DR: The third-generation laser balloon (LB3) offers and automized ablation for rapid PVI was safe and effective for PVI and Procedure time, LA dwelling time and total laser time significantly decreased compared to LB2.

TL;DR: The 2 stage hybrid method combines epicardial and endocardial ablation for drug refractory, long-standing persistent AF and 75% of the 175 patents were in sinus rhythm at latest clinical follow-up including those on antiarrhythmic drugs.

TL;DR: In conclusion, STEMI patients treated with PiCSO were propensity matched to INFUSE-AMI controls and infarct size at day 5 was significantly lower in the Pi CSO group.

TL;DR: In patients with AMI, a high PRECISE-DAPT score was associated with higher long-term all-cause mortality, as well as risk stratification of bleeding, and this score is useful for predicting all- cause mortality.

TL;DR: A review of the published case reports and series and pertinent outcomes of TTS in COVID-19 aimed to perform a review of existing data on Takotsubo syndrome.

TL;DR: This study is the largest European real-world study ever published on NOACs and includes all Italian patients treated with NOacs since 2013 accounting for about 1/3 of subjects with AF.

TL;DR: Alation Index-guided ablation allows for ablation lesions of consistent depth and Wall thickness adjusted Ablation Index targets may improve ablation outcomes.

TL;DR: The association of Corona virus disease (COVID-19) pandemic and incidence of acute myocardial infarction with cardiogenic shock (MI-CS) could not be identified, and a significant association of the national lockdown on the incidence of MI-CS was not identified.

TL;DR: Myocardial injury represents an increased risk of complications and death in Mexican hospitalized patients with COVID-19 and was associated to the same factors as overweight/obesity.

TL;DR: An overview of CA with a special focus on current and emerging diagnostic modalities is provided and a diagnostic algorithm for the evaluation of patients with suspected CA in every-day practice is provided.

TL;DR: The overall reduced bleeding rates, but increased early definite and probable stent thrombosis rates with double versus triple antithrombotic therapy encourage consideration of triple therapy during the first weeks from PCI followed by double therapy.

TL;DR: Vitamin D did not reduce CHD and stroke and a linear relationship does not exist between baseline 25(OH)D and vitamin D supplementation’s effect on CVD.

TL;DR: Recognizing sleep health as a modifiable risk factor is vital to CV health and PNS is a promising new therapy for CSA to restore normal breathing patterns.

TL;DR: In case reports by Chadha et al and Sofia et al, during hospitalization both the patients presented with chest pain and anxiety due to COVID-19 pandemic and both of them were Postmenopausal women with mean age of 82 years, and both ECG and Echocardiography were consistent with the TTS.

TL;DR: First clinical outcomes of a new thin strut cobalt chromium biolimus-eluting stent met the primary endpoint and pre-specified comparison with the LEADERS (BES arm) trial met non-inferiority.

TL;DR: The burden of CVDs in Nepal including, prevalence, incidence, and disability basis as well as trends over the past two decades by age and gender are reported, with the burden greater among males and among older age groups.